(Q79329253)
Statements
A Phase II study of acute toxicity for Celebrex (celecoxib) and chemoradiation in patients with locally advanced cervical cancer: primary endpoint analysis of RTOG 0128 (English)
David K Gaffney
Kathryn Winter
Brigitte Miller
Patricia J Eifel
Janice Ryu
Vilija Avizonis
Mitch Fromm
2 November 2006